Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1996
12/10/1996CA1338775C Water soluble monoesters as solubilisers for pharmacologicably active compounds and pharmaceutical excipients
12/07/1996CA2173043A1 Thickened and stabilized cosmetic emulsion compositions
12/05/1996WO1996038571A2 Recombinant polypeptide cytotoxins for cancer treatment
12/05/1996WO1996038461A1 Cleavage of rna using metal complexes
12/05/1996WO1996038175A1 Stabilized composition comprising an antiulcerative benzimidazole
12/05/1996WO1996038174A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/05/1996WO1996038162A1 Method of using lectins for prevention and treatment of skin diseases and disorders
12/05/1996WO1996038161A1 Drug delivery enhancement via modified saponins
12/05/1996WO1996038153A1 Stabilized solid dispersions of misoprostol
12/05/1996WO1996038138A1 Novel taxoids
12/05/1996WO1996038136A1 Localized use of nitric oxide-adducts to prevent internal tissue damage
12/05/1996WO1996038135A1 Sorbic-acid-containing hydrogels
12/05/1996DE19523478C1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations
12/05/1996CA2762921A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996CA2223063A1 Drug delivery enhancement via modified saponins
12/05/1996CA2222566A1 Hydrogels that contain sorbic acid
12/05/1996CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745391A1 Apparatus, method and composition for preserving media in tip of solution dispenser
12/04/1996EP0745390A2 Polymeric prodrugs for beta-lactamase and uses thereof
12/04/1996EP0745389A1 Composition for topical application
12/04/1996EP0745388A1 Mammalian vaccines composition comprising squalene or squalane, phospholipid and a surfactant as adjuvant
12/04/1996EP0745387A2 Adjuvants for viral vaccines
12/04/1996EP0745383A2 An enteric preparation coated with a non-solvent enteric coating agent using a liquid plasticizer
12/04/1996EP0745382A1 Intraorally soluble compressed molding and process for producing the same
12/04/1996EP0745381A1 A process for preparing pharmaceutical compositions through deposition of complexes of drugs with cyclodextrins on inert or active cores
12/04/1996EP0745372A1 Use of colloidal silicic acid to reinforce keratineous fibres
12/04/1996EP0745134A1 Nucleic acid delivery system, method of synthesis and uses thereof
12/04/1996EP0745085A1 Texaphyrin metal complexes having improved functionalization
12/04/1996EP0744959A1 Treatment of antibiotic associated diarrhea
12/04/1996EP0744958A1 Polyclonal antibody libraries
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0744951A1 Process for producing a sterile prednisolone gel
12/04/1996EP0744947A1 Modified-release metronidazole compositions and methods for making and using same
12/04/1996EP0744946A1 Compositions containing micronized nebivolol
12/04/1996EP0744944A1 Sexual steroid-containing transdermal therapeutic systems
12/04/1996EP0744942A1 Controlled release hydrogel formulation
12/04/1996EP0744941A1 Process for preparing fine particle pharmaceutical formulations
12/04/1996EP0744940A1 Drugs, vaccines and hormones in polylactide coated microspheres
12/04/1996EP0744939A1 Bilayer preparations
12/04/1996EP0744938A1 Liquid ophthalmic sustained release delivery system
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0648115B1 Composition for controlled release of an active substance and method for the preparation of such a composition
12/04/1996EP0640104B1 Copolymers based on vinyl ethers and monoethylenically unsaturated dicarboxylic acid anhydrides, process for producing the same and their use
12/04/1996EP0630230B1 Pharmaceutical inhalation compositions
12/04/1996EP0547191B1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996CN1137280A Water soluble active sulfones of poly (ethylene glycol) and relative polymer for modifying surface and molecule of substances
12/04/1996CN1137238A Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
12/04/1996CN1137223A Growth promoting composition for fish
12/04/1996CN1136918A Single-shot vaccine formulation
12/03/1996US5580974 Prepared by heating suspension of cellulose and persulfate salt in acid to oxidize, isolating product
12/03/1996US5580963 Proteolysis resistance
12/03/1996US5580929 Volume changes in response to physical or chemical stimuli
12/03/1996US5580904 Penetrate blood-brain barrier
12/03/1996US5580902 Applying ethyl pyruvate solutions to reduce facial wrinkling
12/03/1996US5580901 Percutaneous anesthetics
12/03/1996US5580856 Formulation of a reconstituted protein, and method and kit for the production thereof
12/03/1996US5580851 Inclusion complex of cyclodetrin and perfume
12/03/1996US5580580 3-aminopyridine or 3,4-diaminopyridine; useful for multiple sclerosis and alzheimer's disease
12/03/1996US5580576 Pharmaceutically/storage-stable nicorandil formulations
12/03/1996US5580575 Therapeutic drug delivery systems
12/03/1996US5580574 Including a benzodiazepine antagonist to overcome the sedative effects of the benzodiazepine active ingredient
12/03/1996US5580572 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
12/03/1996US5580568 Tantalum, tantalum oxide and barium sulfate used as contrast agent, dimethyl sulfoxide used as biocompatible solvent; injecting embolizing agent into blood vessel
12/03/1996US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
12/03/1996US5580543 Texaphyrins as radiation sensitizers
12/01/1996CA2177644A1 Polymeric prodrugs for beta-lactamase and uses thereof
12/01/1996CA2177538A1 Apparatus, method and composition for preserving media in tip of solution dispenser
11/1996
11/28/1996WO1996037519A1 A polysaccharide hydrogel material, a process for its preparation and its use in medicine, surgery, cosmetics and for the preparation of health care products
11/28/1996WO1996037516A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/28/1996WO1996037515A1 Process of high purity albumin production
11/28/1996WO1996037233A1 Polymyxin conjugates
11/28/1996WO1996037231A1 Skin permeation enhancer compositions using acyl lactylates
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996WO1996037209A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
11/28/1996WO1996037202A1 Dosage form comprising oxybutynin
11/28/1996WO1996037196A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996WO1996037191A1 Antibacterial compositions
11/28/1996WO1996037190A1 Stable, concentrated, locally-tolerated erythromycylamine solutions
11/28/1996WO1996037180A1 Stabilized pseudo-emulsions and their preparation process
11/28/1996WO1996033695A3 Gel with increased oxygen content
11/28/1996WO1996032931A3 Composite with sodium starch glycolate as a support material and products thereof
11/28/1996DE19518917A1 Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen Stable, concentrated locally acceptable solutions erythromycylamine
11/28/1996DE19517145C1 Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron Transdermal therapeutic system (TTS) for the administration of testosterone
11/28/1996CA2510391A1 Dosage form comprising oxybutynin
11/28/1996CA2222018A1 Oral dosage composition for intestinal delivery and method of use of the same
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2219778A1 Polymyxin conjugates
11/28/1996CA2219479A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/28/1996CA2217029A1 Skin permeation enhancer compositions using acyl lactylates
11/28/1996CA2191597A1 Antibacterial compositions
11/27/1996EP0743984A1 Nucleic acid-containing composition, its preparation and use
11/27/1996EP0743958A1 Non-viral vector
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743860A1 Preparation of hollow microcapsules
11/27/1996EP0743857A1 Method of making polymers having specific properties
11/27/1996EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
11/27/1996EP0743854A1 Anti-tumour medical preparation on the basis of carboplatin and the method of its production
1 ... 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 ... 1712